Genaco
	Developer of molecular diagnostic technology and products. The company\'s main products include commercial kits for prenatal screening and diagnosis of common genetic diseases.
	['', 'molecular diagnostic technology', ' ', 'prenatal screening', ' ', 'genetic diseases', '']
Allergene
	Developer of products for diseases relating to immune system dysfunction. The company provides treatment of diseases that affect the immune system, ranging from allergies to AIDS.
	['nontoxic alternative modification']
TaiMed Biologics
	Developer of biotechnology prevention and treatment solutions for viral infectious diseases that are causing serious harm to human health. Products in research include Tamiphosphor, a neuraminidase inhibitor for the treatment of influenza, and Ibalizumab, an HIV prophylactic drug.
	['influenza HIV']
SemBioSys Genetics
	Developer of biotechnology solutions. The company focuses in the development stage of agricultural biotechnology that utilizes plant seed based oilbody and genetic expression technology platforms to develop high value proteins and oils and drug candidates in oil seed producing plant species.
	['', 'pharmaceuticals and biotechnology', ' ', 'agricultural biotechnology', ' ', 'life sciences', '']
Santaris Pharma
	Developer of ribonucleic acid (RNA) targeted therapies. The company\'s Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine  is designed to deliver single-stranded Locked Nucleic Acid (LNA) based drug candidates across an array of disease states, including  cancer, cardiovascular disease, infectious and inflammatory diseases and rare genetic disorders.
	['', 'nucleic acid', ' ', 'drug discovery engine', ' ', 'ribonucleic acid', '']
Eisai Company
	Eisai is a healthcare company, which provides prescription pharmaceuticals, consumer health care products, and diagnostics services.
	['']
CytoPherx
	Developer of cytopheresis systems for addressing inflammation-based diseases and conditions. The company focuses on acute renal failure, end-stage renal disease, and acute inflammation induced by cardio pulmonary bypass surgery. It develops products based on the configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient\'s blood system.
	['', 'inflammation-based diseases', ' ', 'cardio pulmonary bypass surgery', ' ', 'Therapeutic Device', '']
Xenon Pharmaceuticals
	Developer of medicines focused on rare diseases. The company\'s core enabling discovery platform is focused on studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
	['', 'rare disease', ' channelopathy ', 'gene therapy', ' ', 'discovery platform', ' ', 'ion channel mutation', '']
Sanofi Genzyme
	Manufacturer of human health-care products. The company focuses on rare genetic disease disorders, renal diseases, orthopedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. It operates as a biotechnology company worldwide.
	['biotechnology ', 'genetic disorder', ' ', 'renal disease', ' ', 'cancer treatment', ' ', 'lysosomal storage disorder', ' ', 'genetic disease', ' ', 'chronic disease', ' oncology']
Phoenix Bioscience
	Provider of MEMS-based technologies for diagnostic applications. The company focuses on developing affordable treatments for immune dysfunctions. The company\'s product drug PBS119 is used for treating HIV virus.
	['', 'diagnostic applications', ' ', 'drug PBS119', ' HIV virus']
